Congratulations to Memic Innovative Surgery (“Memic”), an Israeli medical device company dedicated to transforming robot-assisted surgery with its proprietary technology, on completing a multimillion dollar Series D Financing Round.

Leading
Continue Reading GT Team Represents Medical Device Company in Series D Financing

Greenberg Traurig is extremely proud to represent Redhill Biopharma with the recent announcement of providing an initial update on the compassionate use program with its investigational drug, opaganib, in patients
Continue Reading Greenberg Traurig Is Proud to Represent Redhill Biopharma Treating COVID-19 Patient with Opaganib in Israel Under Compassionate Use